The Andersons, Inc. Reports Fourth Quarter and Full Year Results
Financial Highlights:
Full year net income attributable to The Andersons of $114 million , or $3.32 per diluted share, and $117 million , or $3.40 per diluted share, on an adjusted basis
Fourth quarter net income attributable to The Andersons of $45 million , or $1.31 per diluted share, and $47 million , or $1.36 per diluted share, on an adjusted basis
Adjusted EBITDA of $363 million for the year, and $117 million for the fourth quarter
Trade reported record fourth quarter pretax income of $54 million on solid operations
Renewables reported pretax income of $25 million and pretax income attributable to the company of $16 million on efficient plant performance and solid merchandising
Strong balance sheet; healthy cash flows result in a cash balance of $562 million
"Trade had an excellent fourth quarter, with an early harvest, where we were able to accumulate higher-than-normal quality grain at good basis values. We also saw some improved merchandising opportunities and good results in our premium ingredients business. We are integrating Skyland Grain, LLC locations into our trade flows and this report includes two months of results from that recent investment. Renewables also had a very solid quarter but could not duplicate 2023 despite record ethanol production due to lower ethanol prices and co-product values. In Nutrient & Industrial, we had year-over-year improvement led by our manufactured product lines that helped offset soft ag supply chain results due to limited farmer engagement," said President and CEO Bill Krueger . "In these changing ag markets, I'm proud of our team."
"Looking forward, we see continued regulatory and geopolitical uncertainties coupled with potentially challenging agricultural economics. We also see signs of opportunity. We currently expect a significant increase in planted corn acres and continuing strong ethanol exports. Our mix of North American agribusiness and ethanol production assets along with our strength in merchandising, positions us well to withstand downward pressures from these market shifts," added Krueger. "In addition to the recent Skyland Grain investment, we are making progress on several longer-term capital investments that will enhance future results. We also continue to actively pursue growth in the Renewables space, both by lowering the carbon intensity of our ethanol plants as well as evaluating expansion and acquisition opportunities. In December, we announced some changes to improve the alignment of our commercial teams to serve our customers even better, gain operational efficiencies, and continue to drive growth. We are excited about the new Agribusiness and Renewables teams and are working hard to achieve our growth strategy."
$ in millions, except per share amounts
Q4 2024
Q4 2023
Variance
YTD 2024
YTD 2023
Variance
Pretax Income
$ 67.3
$ 91.8
$ (24.5)
$ 200.8
$ 169.6
$ 31.2
Pretax Income Attributable to the Company 1
58.2
64.5
(6.3)
144.1
138.2
5.9
Adjusted Pretax Income (Loss) Attributable to the Company 1
60.6
68.4
(7.8)
146.7
159.1
(12.4)
Trade 1
53.6
47.0
6.6
94.6
83.3
11.3
Renewables 1
16.0
32.7
(16.7)
79.8
97.7
(17.9)
Nutrient & Industrial 1
3.5
2.1
1.4
18.9
25.7
(6.8)
Other 1
(12.5)
(13.4)
0.9
(46.6)
(47.7)
1.1
Net Income Attributable to the Company
45.1
51.2
(6.1)
114.0
101.2
12.8
Adjusted Net Income Attributable to the Company 1
46.9
54.6
(7.7)
116.7
118.3
(1.6)
Diluted Earnings Per Share (EPS)
1.31
1.49
(0.18)
3.32
2.94
0.38
Adjusted EPS 1
1.36
1.59
(0.23)
3.40
3.44
(0.04)
EBITDA 1
113.7
131.2
(17.5)
360.3
341.5
18.8
Adjusted EBITDA 1
$ 116.5
$ 135.1
$ (18.6)
$ 363.4
$ 405.1
$ (41.7)
1 Non-GAAP financial measures; see appendix for explanations and reconciliations.
Cash, Liquidity, and Long-Term Debt Management
"Our businesses continued to generate solid operating cash flows into the fourth quarter. Our cash flows and lower commodity prices resulted in a cash position of more than $560 million at the end of the year. In addition, our debt remains at a modest level, inclusive of debt acquired as part of the Skyland Grain investment," said Executive Vice President and CFO Brian Valentine . "Our long-term debt to adjusted EBITDA ratio of 1.8 times is still well below our stated target of 2.5 times. We were pleased to be able to deploy more capital during the quarter and anticipate increased spending on some of the previously announced growth projects in 2025."
The company generated $269 million and $251 million in cash from operating activities for the fourth quarters of 2024 and 2023, respectively, and generated $100 million and $122 million in cash from operations before working capital changes for the same periods, respectively.
For the full years of 2024 and 2023, the company generated $332 million and $947 million in cash from operating activities, respectively. Cash from operations before working capital changes for the same years was $323 million and $330 million even with the changing ag markets.
Fourth Quarter Segment Overview
Trade Posts Record Fourth Quarter Driven by Solid Operations
Trade recorded pretax income and adjusted pretax income attributable to the company of $54 million for the quarter, compared to pretax income of $44 million and adjusted pretax income of $47 million in the fourth quarter of the prior year.
Solid elevation margins and space income in core grain assets on an early and robust harvest drove results. The merchandising businesses realized improvements over the prior year, despite limited volatility in the grain markets. The premium ingredients business had another consistent and profitable quarter.
The portfolio mix of assets, ingredients, and merchandising businesses provides a solid foundation to benefit from large crops and carry markets, as well as tight, demand-driven markets. With a lower-than-expected corn carryout at the end of the year, an inverse has returned to the corn markets, which could result in an increase in corn acres planted and increased volatility in 2025. Domestic premium ingredient demand is also expected to stay solid and should continue to support recent capital growth investments.
Trade's fourth quarter adjusted EBITDA was $76 million , compared to fourth quarter 2023 adjusted EBITDA of $62 million . For the full year, adjusted EBITDA was $161 million in 2024, compared to $155 million in 2023.
Renewables Reports Solid Quarter on Efficient Operations
The Renewables segment reported pretax income of $25 million and pretax income attributable to the company of $16 million in the fourth quarter compared to pretax income of $60 million and pretax income attributable to the company of $33 million in the fourth quarter of 2023.
Fourth quarter results were down from a prior year record, as ethanol board crush margins were down $0.16 /gallon and co-product values traded lower on reduced corn prices and weaker corn oil values. Partially offsetting these headwinds, the four ethanol plants continued to run efficiently, with record fourth quarter production, and reduced input cost, including lower corn basis of $0.09 /gallon year-over-year. Third-party ethanol merchandising also saw improved profitability in 2024.
While spot ethanol crush margins are generally seasonally soft in the first quarter, a portion of first quarter volumes have been hedged at favorable levels. While there remains regulatory uncertainty, elevated export demand, upcoming planned maintenance in the industry, and the spring driving rebound should all support improved plant economics. Co-product values may also see improvement as there has been a recent rebound in corn values.
Renewables recorded EBITDA of $40 million in the fourth quarter of 2024, compared to 2023 fourth quarter EBITDA of $73 million . For the full year, adjusted EBITDA was $189 million in 2024, compared to $230 million 2023.
Nutrient & Industrial Shows Improvement on Prior Year
Nutrient & Industrial recorded pretax income and pretax income attributable to the company of $3 million in the fourth quarter, an improvement from the prior year. The increased results are primarily due to improvements in manufactured products and one-time prior year expenses that did not repeat. Core agriculture product lines were down year-over-year on softer industry fundamentals. With high yields during harvest pulling more nutrients from the soil and an expected increase in corn acres planted, there may be an opportunity for increased volume in 2025.
Nutrient & Industrial's current quarter EBITDA was $13 million , compared to adjusted EBITDA of $11 million in 2023. For the full year, Nutrient & Industrial recorded EBITDA of $57 million in 2024, compared to adjusted EBITDA of $62 million in 2023.
Income Taxes
The company recorded income tax expense at an effective rate of 20% for the fourth quarter and 15% for the year. This rate was impacted by the tax treatment of noncontrolling interests and federal tax credits; a significant portion are biofuel tax credits related to the production of cellulosic ethanol.
Conference Call
The company will host a webcast on Wednesday, February 19, 2025 , at 8:30 a.m. ET , to discuss its performance and provide its outlook for 2025. To access the call, please dial 888-317-6003 or 412-317-6061 (international toll) and use elite entry number: 3381023. It is recommended that you call 10 minutes before the conference call begins.
To access the webcast, click on the link: https://app.webinar.net/k56MoWjneK8 and submit the requested information as directed. A replay of the call can also be accessed under the heading "Investors" on the company's website at www.andersonsinc.com.
Forward-Looking Statements
This release contains forward-looking statements. These statements involve risks and uncertainties that could cause actual results to differ materially. Without limitation, these risks include economic, weather and regulatory conditions, competition, geopolitical risk, and the risk factors set forth from time to time in the company's filings with the Securities and Exchange Commission. Although the company believes that the assumptions upon which the financial information and its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct.
Non-GAAP Measures
This release contains non-GAAP financial measures. The company believes that pretax income (loss) attributable to the company; adjusted pretax income (loss) attributable to the company; adjusted pretax income (loss); adjusted net income attributable to the company; adjusted diluted earnings per share; earnings before interest, taxes, depreciation, and amortization (or EBITDA); adjusted EBITDA; and cash from operations before working capital changes provide additional information to investors and others about its operations, allowing an evaluation of underlying operating performance and liquidity and better period-to-period comparability. The above measures are not and should not be considered as alternatives to pretax income (loss) or income (loss) before income taxes, net income (loss), diluted earnings (loss) per share attributable to The Andersons, Inc. common shareholders and cash provided by (used in) operating activities as determined by generally accepted accounting principles. Reconciliations of the GAAP to non-GAAP measures may be found within this press release and the financial tables provided herein.
Company Description
The Andersons, Inc., named in 2024 as one of The Americas' Fastest Growing Companies by the Financial Times and one of America's Climate Leaders by USA Today, is a diversified company rooted in agriculture that conducts business in the agribusiness and renewables sectors. Guided by its Statement of Principles, The Andersons is committed to providing extraordinary service to its customers, helping its employees improve, supporting its communities, and increasing the value of the company. For more information, please visit www.andersonsinc.com.
The Andersons, Inc.
Condensed Consolidated Balance Sheets
(unaudited)
(in thousands)
December 31, 2024
December 31, 2023
Assets
Current assets:
Cash and cash equivalents
$ 561,771
$ 643,854
Accounts receivable, net
764,550
762,549
Inventories
1,286,811
1,166,700
Commodity derivative assets – current
148,801
178,083
Other current assets
88,344
55,777
Total current assets
2,850,277
2,806,963
Other assets:
Goodwill
127,856
127,856
Other intangible assets, net
69,345
85,579
Right of use assets, net
104,630
54,234
Other assets, net
101,055
87,010
Total other assets
402,886
354,679
Property, plant and equipment, net
868,151
693,365
Total assets
$ 4,121,314
$ 3,855,007
Liabilities and equity
Current liabilities:
Short-term debt
$ 166,614
$ 43,106
Trade and other payables
1,047,436
1,055,473
Customer prepayments and deferred revenue
194,025
187,054
Commodity derivative liabilities – current
59,766
90,849
Current maturities of long-term debt
36,139
27,561
Accrued expenses and other current liabilities
227,192
232,288
Total current liabilities
1,731,172
1,636,331
Long-term lease liabilities
65,312
31,659
Long-term debt, less current maturities
608,151
562,960
Deferred income taxes
55,005
58,581
Other long-term liabilities
61,838
49,089
Total liabilities
2,521,478
2,338,620
Total equity
1,599,836
1,516,387
Total liabilities and equity
$ 4,121,314
$ 3,855,007
The Andersons, Inc.
Consolidated Statements of Cash Flows
(unaudited)
Three months ended
December 31,
Twelve months ended
December 31,
(in thousands)
2024
2023
2024
2023
Operating Activities
Net income
$ 54,104
$ 78,437
$ 170,700
$ 132,529
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization
36,178
31,306
127,804
125,106
Bad debt expense, net
6,138
5,438
17,637
11,519
Stock-based compensation expense
3,611
3,493
13,629
12,857
Asset impairment
—
—
—
87,156
Deferred federal income tax
(1,997)
6,696
(2,911)
(1,596)
Other
1,862
(10,535)
(3,595)
(16,341)
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed:
Accounts and notes receivable
32,279
62,705
35,777
468,968
Inventories
(191,041)
(175,883)
87,906
572,235
Commodity derivatives
(34,322)
12,027
15,005
111,506
Other current and non-current assets
31,326
4,481
(28,050)
6,529
Payables and other current and non-current liabilities
330,673
232,498
(102,396)
(563,718)
Net cash provided by operating activities
268,811
250,663
331,506
946,750
Investing Activities
Acquisition of businesses, net of cash acquired
(19,611)
(313)
(29,172)
(24,698)
Purchases of property, plant and equipment and capitalized software
(55,957)
(41,725)
(149,187)
(150,443)
Property insurance proceeds
2,918
4,999
12,137
7,499
Proceeds from sale of business
—
—
—
10,318
Proceeds from sale of Rail assets
—
—
—
2,871
Other
168
423
3,148
574
Net cash used in investing activities
(72,482)
(36,616)
(163,074)
(153,879)
Financing Activities
Net (payments) receipts under short-term lines of credit
(64,897)
27,456
(91,951)
(233,696)
Proceeds from issuance of long-term debt
67,000
—
67,000
100,000
Payments of long-term debt
(62,940)
(6,886)
(83,589)
(49,620)
Distributions to noncontrolling interest owner
(14,970)
(2,114)
(102,295)
(46,418)
Dividends paid
(6,807)
(6,602)
(26,273)
(25,373)
Common stock repurchased
(2,295)
—
(2,295)
(1,747)
Payments of debt issuance costs
(2,851)
—
(2,851)
—
Value of shares withheld for taxes
(4)
(3)
(8,105)
(6,630)
Other
—
2
—
(509)
Net cash provided by (used in) financing activities
(87,764)
11,853
(250,359)
(263,993)
Effect of exchange rates on cash and cash equivalents
(859)
(101)
(156)
(293)
Increase (decrease) in Cash and cash equivalents
107,706
225,799
(82,083)
528,585
Cash and cash equivalents at the beginning of the period
454,065
418,055
643,854
115,269
Cash and cash equivalents at the end of the period
$ 561,771
$ 643,854
$ 561,771
$ 643,854
The Andersons, Inc.
Adjusted Net Income Attributable to The Andersons, Inc.
A non-GAAP financial measure
(unaudited)
Three months ended
December 31,
Twelve months ended
December 31,
(in thousands, except per share data)
2024
2023
2024
2023
Net income
$ 54,104
$ 78,437
$ 170,700
$ 132,529
Net income attributable to noncontrolling interests
9,014
27,251
56,688
31,339
Net income attributable to The Andersons, Inc.
45,090
51,186
114,012
101,190
Adjustments:
Transaction related compensation
2,536
3,212
11,104
7,818
Insurance recoveries
(4,446)
—
(9,650)
(16,080)
Gain on deconsolidation of joint venture
—
—
(3,117)
(6,544)
Acquisition costs
2,738
—
2,738
—
(Gain) loss on cost method investment
1,535
—
1,535
(4,798)
Asset impairment
—
—
—
45,413
Gain on sale of assets
—
—
—
(5,643)
Goodwill impairment
—
686
—
686
Income tax impact of adjustments 1
(590)
(520)
42
(3,775)
Total adjusting items, net of tax
1,773
3,378
2,652
17,077
Adjusted net income attributable to The Andersons, Inc.
$ 46,863
$ 54,564
$ 116,664
$ 118,267
Diluted earnings per share attributable to The Andersons, Inc. common shareholders
$ 1.31
$ 1.49
$ 3.32
$ 2.94
Impact on diluted earnings per share
$ 0.05
$ 0.10
$ 0.08
$ 0.50
Adjusted diluted earnings per share attributable to The Andersons, Inc. common shareholders
$ 1.36
$ 1.59
$ 3.40
$ 3.44
1
The income tax impact of adjustments is taken at the blended federal, state, and local tax rate of 25% with the exception of certain transaction related compensation, certain acquisition costs, and goodwill impairments in both 2024 and 2023, respectively.
Adjusted net income (loss) attributable to The Andersons, Inc. reflects reported net income (loss) available to The Andersons, Inc. common shareholders after the removal of specified items described above. Adjusted diluted earnings (loss) per share reflects the fully diluted EPS of The Andersons, Inc. after removal of the effect on EPS as reported of specified items described above. Management believes that Adjusted net income (loss) attributable to The Andersons, Inc. and Adjusted diluted earnings (loss) per share are useful measures of The Andersons, Inc. performance as they provide investors additional information about the operations of the company allowing better evaluation of underlying business performance and better comparability to previous periods. These non-GAAP financial measures are not intended to replace or be alternatives to Net income attributable to The Andersons, Inc. and Diluted earnings attributable to The Andersons, Inc. common shareholders as reported, the most directly comparable GAAP financial measures, or any other measures of operating results under GAAP. Earnings amounts described above have been divided by the company's average number of diluted shares outstanding for each respective period in order to arrive at an adjusted diluted earnings (loss) per share amount for each specified item.
The Andersons, Inc.
Segment Data
(unaudited)
(in thousands)
Trade
Renewables
Nutrient &
Industrial
Other
Total
Three months ended December 31, 2024
Sales and merchandising revenues
$ 2,222,762
$ 713,958
$ 186,418
$ —
$ 3,123,138
Gross profit
146,976
35,479
30,655
—
213,110
Operating, administrative and general expenses
95,504
10,901
27,811
12,938
147,154
Other income (loss), net
10,441
992
1,564
(1,437)
11,560
Income (loss) before income taxes
53,818
24,921
2,551
(14,040)
67,250
Income (loss) attributable to noncontrolling interests
1,018
8,941
(945)
—
9,014
Income (loss) before income taxes attributable to The Andersons, Inc. 1
$ 52,800
$ 15,980
$ 3,496
$ (14,040)
$ 58,236
Adjustments to income (loss) before income taxes 2
828
—
—
1,535
2,363
Adjusted income (loss) before income taxes attributable to The Andersons, Inc. 1
$ 53,628
$ 15,980
$ 3,496
$ (12,505)
$ 60,599
Three months ended December 31, 2023
Sales and merchandising revenues
$ 2,212,434
$ 795,236
$ 205,330
$ —
$ 3,213,000
Gross profit
126,064
65,257
26,393
—
217,714
Operating, administrative and general expenses
88,097
7,933
24,091
12,591
132,712
Other income (loss), net
11,839
3,401
439
(819)
14,860
Income (loss) before income taxes
43,807
59,988
1,374
(13,408)
91,761
Income attributable to noncontrolling interests
—
27,251
—
—
27,251
Income (loss) before income taxes attributable to The Andersons, Inc. 1
$ 43,807
$ 32,737
$ 1,374
$ (13,408)
$ 64,510
Adjustments to income (loss) before income taxes 2
3,212
—
686
—
3,898
Adjusted income (loss) before income taxes attributable to The Andersons, Inc. 1
$ 47,019
$ 32,737
$ 2,060
$ (13,408)
$ 68,408
1
Income (loss) before income taxes attributable to The Andersons, Inc. for each operating segment is defined as net sales and merchandising revenues plus identifiable other income less all identifiable operating expenses, including interest expense for carrying working capital and long-term assets and is reported net of the noncontrolling interest share of income.
2
Additional information on the individual adjustments that are included in the adjustments to income (loss) before income taxes can be found in the Reconciliation to EBITDA and Adjusted EBITDA table. All adjustments are consistent with the EBITDA reconciliation with the exception of items where a portion of the expense is attributable to the noncontrolling interest and is represented in Income attributable to the noncontrolling interest within the reconciliation above. These adjustments include a $0.5 million difference in acquisition costs in the Trade segment for the three months ended December 31, 2024.
The Andersons, Inc.
(unaudited)
(in thousands)
Trade
Renewables
Nutrient &
Industrial
Other
Total
Twelve months ended December 31, 2024
Sales and merchandising revenues
$ 7,622,077
$ 2,802,330
$ 833,141
$ —
$ 11,257,548
Gross profit
403,682
169,151
121,093
—
693,926
Operating, administrative and general expenses
316,390
35,493
103,238
48,499
503,620
Other income (loss), net
28,728
8,678
6,444
(1,639)
42,211
Income (loss) before income taxes
91,433
139,495
17,988
(48,159)
200,757
Income (loss) attributable to noncontrolling interests
1,018
56,615
(945)
—
56,688
Income (loss) before income taxes attributable to The Andersons, Inc. 1
$ 90,415
$ 82,880
$ 18,933
$ (48,159)
$ 144,069
Adjustments to income (loss) before income taxes 2
4,192
(3,117)
—
1,535
2,610
Adjusted income (loss) before income taxes attributable to The Andersons, Inc. 1
$ 94,607
$ 79,763
$ 18,933
$ (46,624)
$ 146,679
Twelve months ended December 31, 2023
Sales and merchandising revenues
$ 10,426,083
$ 3,380,632
$ 943,397
$ —
$ 14,750,112
Gross profit
409,950
202,397
133,016
—
745,363
Operating, administrative and general expenses
308,470
32,737
103,342
47,711
492,260
Other income, net
29,988
15,056
2,391
3,048
50,483
Income (loss) before income taxes
96,234
91,175
25,049
(42,895)
169,563
Income attributable to noncontrolling interests
—
31,339
—
—
31,339
Income (loss) before income taxes attributable to The Andersons, Inc. 1
$ 96,234
$ 59,836
$ 25,049
$ (42,895)
$ 138,224
Adjustments to income (loss) before income taxes 2
(12,942)
37,906
686
(4,798)
20,852
Adjusted income (loss) before income taxes attributable to The Andersons, Inc. 1
$ 83,292
$ 97,742
$ 25,735
$ (47,693)
$ 159,076
1
Income (loss) before income taxes attributable to The Andersons, Inc. for each operating segment is defined as net sales and merchandising revenues plus identifiable other income less all identifiable operating expenses, including interest expense for carrying working capital and long-term assets and is reported net of the noncontrolling interest share of income.
2
Additional information on the individual adjustments that are included in the adjustments to income (loss) before income taxes can be found in the Reconciliation to EBITDA and Adjusted EBITDA table. All adjustments are consistent with the EBITDA reconciliation with the exception of items where a portion of the expense is attributable to the noncontrolling interest and is represented in Income attributable to the noncontrolling interest within the reconciliation above. These adjustments include a $0.5 million difference in acquisition costs in the Trade segment for the year ended December 31, 2024, and a $42.7 million difference in asset impairment expense in the Renewables segment for the year ended December 31, 2023.
(in thousands)
Trade
Renewables
Nutrient &
Industrial
Other
Total
Three months ended December 31, 2024
Net income (loss)
$ 53,818
$ 24,921
$ 2,551
$ (27,186)
$ 54,104
Interest expense (income)
8,095
649
1,857
(335)
10,266
Tax provision
—
—
—
13,146
13,146
Depreciation and amortization
12,559
14,079
8,585
955
36,178
EBITDA
74,472
39,649
12,993
(13,420)
113,694
Adjusting items impacting EBITDA:
Acquisition costs
3,193
—
—
—
3,193
Transaction related compensation
2,536
—
—
—
2,536
Insurance recoveries
(4,446)
—
—
—
(4,446)
Loss on cost method investment
—
—
—
1,535
1,535
Total adjusting items
1,283
—
—
1,535
2,818
Adjusted EBITDA
$ 75,755
$ 39,649
$ 12,993
$ (11,885)
$ 116,512
Three months ended December 31, 2023
Net income (loss)
$ 43,807
$ 59,988
$ 1,374
$ (26,732)
$ 78,437
Interest expense (income)
5,999
737
1,367
(2)
8,101
Tax provision
—
—
—
13,324
13,324
Depreciation and amortization
9,450
12,184
7,750
1,922
31,306
EBITDA
59,256
72,909
10,491
(11,488)
131,168
Adjusting items impacting EBITDA:
Transaction related compensation
3,212
—
—
—
3,212
Goodwill impairment
—
—
686
—
686
Total adjusting items
3,212
—
686
—
3,898
Adjusted EBITDA
$ 62,468
$ 72,909
$ 11,177
$ (11,488)
$ 135,066
Adjusted EBITDA is defined as earnings before interest, taxes and depreciation and amortization, adjusted for specified items. The company calculates adjusted EBITDA by removing the impact of specified items and adding back the amounts of interest expense, tax expense and depreciation and amortization to net income (loss). Management believes that adjusted EBITDA is a useful measure of the company's performance as it provides investors additional information about the company's operations allowing better evaluation of underlying business performance and improved comparability to prior periods. Adjusted EBITDA is a non-GAAP financial measure and is not intended to replace or be an alternative to net income (loss), the most directly comparable GAAP financial measure.
(in thousands)
Trade
Renewables
Nutrient &
Industrial
Other
Total
Twelve months ended December 31, 2024
Net income (loss)
$ 91,433
$ 139,495
$ 17,988
$ (78,216)
$ 170,700
Interest expense (income)
24,587
2,841
6,311
(1,979)
31,760
Tax provision
—
—
—
30,057
30,057
Depreciation and amortization
40,505
49,705
32,488
5,106
127,804
EBITDA
156,525
192,041
56,787
(45,032)
360,321
Adjusting items impacting EBITDA:
Transaction related compensation
11,104
—
—
—
11,104
Insurance recoveries
(9,650)
—
—
—
(9,650)
Acquisition costs
3,193
—
—
—
3,193
Gain on deconsolidation of joint venture
—
(3,117)
—
—
(3,117)
Loss on cost method investment
—
—
—
1,535
1,535
Total adjusting items
4,647
(3,117)
—
1,535
3,065
Adjusted EBITDA
$ 161,172
$ 188,924
$ 56,787
$ (43,497)
$ 363,386
Twelve months ended December 31, 2023
Net income (loss)
$ 96,234
$ 91,175
$ 25,049
$ (79,929)
$ 132,529
Interest expense (income)
35,234
6,385
7,016
(1,768)
46,867
Tax provision
—
—
—
37,034
37,034
Depreciation and amortization
36,109
51,408
29,268
8,321
125,106
EBITDA
167,577
148,968
61,333
(36,342)
341,536
Adjusting items impacting EBITDA:
Insurance recoveries
(16,080)
—
—
—
(16,080)
Gain on sale of assets
(5,643)
—
—
—
(5,643)
Transaction related compensation
7,818
—
—
—
7,818
Asset impairment including equity method investments
963
87,156
—
—
88,119
Gain on deconsolidation of joint venture
—
(6,544)
—
—
(6,544)
Goodwill impairment
—
—
686
—
686
Gain on cost method investment
—
—
—
(4,798)
(4,798)
Total adjusting items
(12,942)
80,612
686
(4,798)
63,558
Adjusted EBITDA
$ 154,635
$ 229,580
$ 62,019
$ (41,140)
$ 405,094
Adjusted EBITDA is defined as earnings before interest, taxes and depreciation and amortization, adjusted for specified items. The company calculates adjusted EBITDA by removing the impact of specified items and adding back the amounts of interest expense, tax expense and depreciation and amortization to net income (loss). Management believes that adjusted EBITDA is a useful measure of the company's performance as it provides investors additional information about the company's operations allowing better evaluation of underlying business performance and improved comparability to prior periods. Adjusted EBITDA is a non-GAAP financial measure and is not intended to replace or be an alternative to net income (loss), the most directly comparable GAAP financial measure.
Cash from operations before working capital changes is defined as cash provided by (used in) operating activities before the impact of changes in working capital within the statement of cash flows. The company calculates cash from operations by eliminating the effect of changes in accounts receivable, inventories, commodity derivatives, other current and non-current assets, and payables and other current and non-current liabilities; and adjusted by specific items from the cash provided by (used in) operating activities. Management believes that cash from operations before working capital changes is a useful measure of the company's performance as it provides investors additional information about the company's operations allowing better evaluation of underlying business performance and improved comparability to prior periods. Cash from operations before working capital changes is a non-GAAP financial measure and is not intended to replace or be an alternative to cash provided by (used in) operating activities, the most directly comparable GAAP financial measure.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
B Riley Financial Posts Q2 Profit Jump
Key Points Adjusted net revenue (non-GAAP) reached $51.5 million in Q2 2025, with investment banking and institutional brokerage making up most of the total. The company posted GAAP net income of $12.5 million in Q2 2025 and ended the quarter with no debt with $94.5 million in cash and securities as of June 30, 2025. A one-time dividend of $0.22 per share was declared, but no recurring dividend program was established. These 10 stocks could mint the next wave of millionaires › B. Riley Financial (NASDAQ:RILY), a diversified financial services firm operating across investment banking, wealth management, and asset disposition, released its earnings for the period ended June 30, 2025, on Aug. 7, 2025. The highlight was a debt-free balance sheet, $94.5 million in cash and securities as of June 30, 2025, and GAAP net income of $12.5 million. Adjusted net revenue (non-GAAP) was $51.5 million. There were no published analyst estimates or prior-period comparables for this stand-alone quarter after the carve-out of its securities operations, leaving direct performance comparisons unavailable. Overall, the period reflected stabilization in core businesses and improvements in profitability, but the sustainability of gains remains to be seen. B. Riley Financial's Business and Focus Areas B. Riley Financial operates a mix of capital markets, wealth management, and asset disposition businesses. Its core unit, B. Riley Securities, handles investment banking (which includes services like underwriting new stock or debt offerings and advising on mergers), institutional brokerage (stock and bond trading for clients), and research. Other segments include wealth management, auctions and liquidations, principal investments in communications, and a brands licensing business. The company's most recent focus is on strengthening its capital markets and core advisory practices. It aims to grow its footprint in high-growth sectors, particularly by raising capital for technology clients and expanding expertise in renewables and health care. Key success factors include team expansion and a disciplined approach to returning capital, as evidenced by its dividend announcements. Quarter in Review: Performance, Drivers, and Events The quarter's results spotlight the impact of a recent business carve-out, with B. Riley Securities reporting as the principal operating business for the first time. Adjusted net revenue, which excludes gains related to legacy investment positions, reached $51.5 million in Q2 2025. While institutional brokerage commissions contributed $25.4 million. Capital markets activity improved sequentially, as management noted, 'client activity increased significantly during the quarter, driving sequential improvements in both Institutional Brokerage commissions and Investment Banking revenue.' The company put a spotlight on capital markets products, including convertibles (debt that can become equity), variable rate financings, and continued growth in flexible funding solutions. Over the past year, the company has helped clients raise over $8 billion to support AI-driven investments, reflecting both client demand and the firm's advisory strengths. Additionally, B. Riley Securities added seven senior executives across key industry sectors, such as technology, health care, and real estate, aiming to enhance client service and drive new business. Hosting its 25th annual investor conference strengthened engagement, with several hundred institutional investors and companies attending. The period saw no reporting detail on other B. Riley Financial units such as wealth management, auctions and liquidations, or the brands portfolio. Past quarters showed asset sales and joint ventures, such as a 44 % retained stake in Great American Group, following majority sales and decomposing non-core segments. The company further reduced its exposure to legacy investment positions, as reflected by adjustments in its reported profit. No major product launches or significant new business lines outside capital markets were highlighted in this quarter. From a balance sheet perspective, the company ended with no outstanding debt and $94.5 million in cash and securities as of June 30, 2025, supporting a strong liquidity position. It declared a one-time $0.22 per share dividend, totaling $4.1 million, approved in Q2 2025. Management explicitly stated this was not intended as a recurring program. Looking Ahead: Guidance and Investor Considerations B. Riley Financial's management did not provide any quantitative financial guidance for the next quarter or for fiscal 2025. Instead, management characterized the current phase as one of stabilization and cautious optimism, indicating that improvement 'has continued into Q3 2025.' They also cautioned that the quarter's performance should not be annualized or taken as a reliable indicator for future periods, citing the lumpy nature of capital markets revenue and the effect of non-recurring gains. Investors will want to watch for greater reporting detail in future quarters as the operations of B. Riley Securities and legacy businesses mature post-carve-out. Key factors include sustained deal flow across capital markets, effectiveness of new personnel hires, the recurrence or decline of non-GAAP investment gains, and the approach to future capital returns. The shifting segment structure and changing client activity patterns will remain important variables for tracking the company's trajectory. The quarterly dividend was declared as a one-time event and does not reflect an ongoing policy. Revenue and net income presented using U.S. generally accepted accounting principles (GAAP) unless otherwise noted. Where to invest $1,000 right now When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 1,069%* — a market-crushing outperformance compared to 184% for the S&P 500. They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor. See the stocks » *Stock Advisor returns as of August 13, 2025
Globe and Mail
2 hours ago
- Globe and Mail
TPI Composites, Inc. Advances Chapter 11 Process with Court Approval of First-Day Motions
Secures Access to Liquidity and Financial Flexibility Operations Continue Uninterrupted for Employees, Customers, and Supply Partners Company Focused on Executing Strategic Initiatives for Long-Term Stability SCOTTSDALE, Ariz., Aug. 13, 2025 (GLOBE NEWSWIRE) -- TPI Composites, Inc. (NASDAQ: TPIC) together with its domestic subsidiaries (collectively, 'TPI' or the 'Company') announced today that the U.S. Bankruptcy Court for the Southern District of Texas (the 'Bankruptcy Court') approved all first-day motions filed by the Company in connection with its voluntary chapter 11 proceedings. The approvals provide the Company with the operational flexibility and liquidity necessary to continue normal business operations during the chapter 11 process. Key motions approved include, interim approval for debtor-in-possession financing from its senior secured lenders of up to $82.5 million, the continuation of employee wages and benefits, maintenance of cash management systems, and the authority to pay certain prepetition obligations critical to ongoing operations. 'Our priority is to maintain stability and support for our employees, customers, and partners during this process,' said Bill Siwek, Chief Executive Officer of TPI. 'The court's approval of these first-day motions allows us to focus on executing our strategic initiatives to strengthen the Company for the long term.' Additional Information Additional information regarding the Company's court-supervised process is available at Court filings and other information related to the proceedings are available on a separate website administrated by the Company's claims agent, Kroll, at by calling Kroll representatives at (877) 280-2696 within the U.S. & Canada (or +1 (646) 290-7082 internationally for calls originating outside of the U.S.); or by sending an email to TPIinfo@ About TPI TPI Composites, Inc. is a global company focused on innovative and sustainable solutions to decarbonize and electrify the world. TPI delivers high-quality, costeffective composite solutions through long-term relationships with leading OEMs in the wind markets. TPI is headquartered in Scottsdale, Arizona and operates factories in the U.S., Mexico, Türkiye and India. TPI operates additional engineering development centers in Denmark and Germany and global service training centers in the U.S. and Spain. Forward-Looking Statements This release contains forward-looking statements made pursuant to safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward looking statements include statements, among other things, concerning: the adoption, implementation and consummation of a Chapter 11 plan of reorganization; the commencement of Chapter 11 proceedings in U.S. bankruptcy court; growth of the wind energy and electric vehicle markets and our addressable markets for our products and services; effects on our financial statements and our financial outlook; our business strategy, including anticipated trends and developments in and management plans for our business and the wind industry and other markets in which we operate; future financial results, operating results, revenues, gross margin, operating expenses, profitability, products, projected costs, warranties, our ability to improve our operating margins, and capital expenditures. These forward-looking statements are often characterized by the use of words such as 'estimate,' 'expect,' 'anticipate,' 'potential,' 'project,' 'plan,' 'intend,' 'seek,' 'believe,' 'forecast,' 'foresee,' 'likely,' 'may,' 'should,' 'goal,' 'target,' 'might,' 'will,' 'could,' 'predict,' 'continue' and the negative or plural of these words and other comparable terminology. Forward-looking statements are only predictions based on our current expectations and our projections about future events. You should not place undue reliance on these forward-looking statements. We undertake no obligation to update any of these forward-looking statements for any reason. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to differ materially from those expressed or implied by these statements. These factors include, but are not limited to, the matters discussed in 'Risk Factors,' in our Annual Report on Form 10-K and other subsequent filings with the SEC.
Globe and Mail
2 hours ago
- Globe and Mail
BioSig Technologies Inc. Announces Pricing of $15 Million Public Offering
Los Angeles, CA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. ('BioSig' or the 'Company'), which recently merged with Streamex Exchange Corporation ('Streamex') (NASDAQ: BSGM), today announced the pricing of its previously announced underwritten public offering of 3,852,149 shares of common stock at a public offering price of $3.90 per share. The offering is expected to close on or around August 15, 2025 subject to customary closing conditions. The gross proceeds from the offering, before deducting underwriter discounts and commissions and other estimated offering expenses are expected to be approximately $15,023,381.10. BioSig intends to use the net proceeds from the offering to purchase gold bullion in accordance with its investment policy, for working capital and for general corporate purposes. Clear Street and Needham & Company are acting as joint book-running managers of the offering. The offering is being made pursuant to a shelf registration statement on Form S-3 (File No. 333-276298) declared effective by the Securities and Exchange Commission (the 'SEC') on December 17, 2024. A final prospectus supplement relating to the offering will be filed with the Securities and Exchange Commission, together with an accompanying base prospectus. The securities may be offered only by means of a written prospectus forming a part of the effective registration statement. Copies of the final prospectus supplement relating to the offering, together with the accompanying base prospectus, may be obtained, when available from the SEC's website at from Clear Street, Attention: Syndicate, 4 World Trade Center, 150 Greenwich St, Floor 46, New York, NY 10007, or by email at syndicate@ and Needham & Company, 250 Park Avenue, 10th Floor, New York, NY 10177, Attn: Prospectus Department, prospectus@ or by telephone at (800) 903-3268. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein. BioSig will not, and has been advised by the joint book-running managers that they and their affiliates will not, sell any of these securities in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. About Streamex Streamex is a RWA and gold tokenization company building Institutional grade infrastructure to bring the gold market on chain, enabled by a gold denominated treasury and an institutional grade tokenization platform. Streamex is a wholly owned subsidiary of BioSig Technologies, Inc. About BioSig Technologies BioSig Technologies, Inc. is a medical device technology company with an advanced digital signal processing technology platform, the PURE EP™ Platform that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. The PURE EP™ Platform enables electrophysiologists to acquire raw signal data in real-time—absent of unnecessary noise or interference—to maximize procedural success and minimize unnecessary inefficiencies. As physician advocates, we believe that the ability to maintain the integrity of intracardiac signals with precision and clarity without driving up procedural costs has never been more pertinent. Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential," or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond our control. It is possible that our actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements, depending on factors including whether we will be able to realize the benefits of the acquisition of Streamex, whether shareholder approval of the acquisition and recently announced convertible debenture financing and standby equity purchase agreement will be obtained, and whether we will be able to maintain compliance with Nasdaq's listing criteria in connection with the acquisition and otherwise. For a discussion of other risks and uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in forward-looking statements, see our filings with the Securities and Exchange Commission, including the section titled "Risk Factors" in our Annual Report on Form 10-K, filed with the SEC on April 15, 2025. We assume no obligation to publicly update or revise our forward-looking statements as a result of new information, future events or otherwise, except as required by law.
